David W. Cescon

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

July, 2025

David W. Cescon

Feb 27, 2025, 11:45 | Blog

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Here’s the most recent Breast Cancer…

Jan 29, 2025, 22:27 | Blog

Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared on X: "Phase 3…

Jan 28, 2025, 15:01 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research Digest…

Dec 28, 2024, 15:46 | Drugs

Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC

Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…

Dec 27, 2024, 10:48 | Drugs

Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…

All: 5 Posts: 1 - 100

'

Garo Armen Shares a Personal Story Driving Agenus' Mission in Cancer Care

'

Dr. Oliver Bogler, PhD: Leaving the National Cancer Institute

'

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care

'

Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology

'

Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023